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Background: Congenital malaria is defined as malaria parasitaemia in the first week of life. The reported prevalence
of congenital malaria in sub-Saharan Africa is variable (0 - 46%). Even though the clinical significance of congenital
malaria parasitaemia is uncertain, anti-malarial drugs are empirically prescribed for sick newborns by frontline health
care workers. Data on prevalence of congenital malaria in high-risk newborns will inform appropriate drug use and
timely referral of sick newborns.
Methods: Blood samples of untreated newborns less than 1 week of age at the time of referral to Korle Bu
Teaching hospital in Accra, Ghana during the peak malaria seasons (April to July) of 2008 and 2010 were examined
for malaria parasites by, i) Giemsa-stained thick and thin blood smears for parasite count and species identification,
ii) histidine-rich protein- and lactic dehydrogenase-based rapid diagnosis tests, or iii) polymerase chain reaction
amplification of the merozoite surface protein 2 gene, for identification of sub-microscopic parasitaemia. Other
investigations were also done as clinically indicated.
Results: In 2008, nine cases of Plasmodium falciparum parasitaemia were diagnosed by microscopy in 405 (2.2%)
newborns. All the nine newborns had low parasite densities (≤50 per microlitre). In 2010, there was no case of
parasitaemia by either microscopy or rapid diagnosis tests in 522 newborns; however, 56/467 (12%) cases of
P. falciparum were detected by polymerase chain reaction.
Conclusion: Congenital malaria is an uncommon cause of clinical illness in high-risk untreated newborns referred
to a tertiary hospital in the first week of life. Empirical anti-malarial drug treatment for sick newborns without
laboratory confirmation of parasitaemia is imprudent. Early referral of sick newborns to hospitals with resources
and skills for appropriate care is recommended.
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Malaria in pregnancy is a major underlying cause of neo-
natal morbidity in endemic regions [1-3]. The burden of
malaria in pregnancy is highest in sub-Saharan Africa
where 1:4 pregnant women have evidence of placental in-
fection at the time of delivery [4-6]. Pregnancy associated
malaria has been implicated as a cause of stillbirths, pre-
mature births, intrauterine growth restriction and conse-
quently low birth weight (LBW) in affected newborns.
However, its effect as a cause of clinical disease in the
newborn especially in the first week of life, when most
newborn illnesses and deaths occur, is uncertain.* Correspondence: chikalaryea@gmail.com
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distribution, and reproduction in any mediumCongenital malaria, defined as malaria parasitaemia in
the first week of life can be acquired transplacentally or
during the time of birth. The prevalence in sub-Saharan
Africa has been reported to vary from 0 – 46% [7]; how-
ever, more recent multicentre longitudinal studies have
reported lower rates of 4 – 6% [8,9]. Clinical malaria is rare
in newborns from endemic areas with high incidence of
malaria in pregnancy. This rare occurrence has been attrib-
uted to the transplacental transfer of maternally derived
antibodies to malaria, and the inhibitory effect of foetal
haemoglobin on malaria parasite development [10-12].
The prevalence of congenital malaria in a community
based prospective study in infants in southern Ghana
in 1998 was 13.6% by polymerase chain reaction (PCR)
and 2.5% by microscopy [13]. In that study the risk ofd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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(April – July) as compared to the dry season. Recently,
two cases of symptomatic congenital malaria were
reported in Ghanaian newborns [14,15].
Clinical malaria in the newborn usually manifests after
the first week of life (but has been reported on day 1) with
symptoms such as fever, poor feeding, lethargy, anaemia,
hepatosplenomegaly, jaundice, irritability, and drowsiness.
These clinical features are similar to the manifestations of
neonatal sepsis and other neonatal conditions that more
commonly cause morbidity and mortality in the newborn
period [8,16,17]. Many malaria endemic sub-Saharan
African countries lack quality laboratory equipment and
skilled frontline health care workers in primary health care
facilities. As such, diagnosing neonatal problems is a major
challenge and empirical treatment for malaria is often
prescribed when newborns first present with the above
symptoms. Sick newborns are referred to hospital few days
later when malaria treatment does not resolve symptoms.
This practice results in delayed referral of sick newborns
for appropriate care and contributes to the high neonatal
mortality and long-term morbidity in survivors in the sub-
region.
Malaria is endemic in Ghana and World Health
Organization (WHO) guidelines for empirical treatment
of malaria in suspected cases is widely adhered to [18].
This practice is extended to sick newborns by primary
care health workers contrary to existing guidelines on
the Integrated Management of Childhood Illnesses.
Though many underlying reasons may account for this
practice in sick newborns, the lack of sufficient local
data on congenital malaria may be a contributory factor.
This study presents the prevalence of malaria parasit-
aemia in non-treated high-risk newborns referred to a
teaching hospital in the first week of life.
Methods
This cross-sectional study was done at the newborn unit
and malaria research laboratory of the Department of
Child Health, Korle Bu Teaching Hospital, in Accra dur-
ing the peak malaria seasons (April – July) of 2008 and
2010. The 55-bed newborn unit serves as a tertiary refer-
ral centre for sick and low birth weight or preterm new-
borns from southern regions of Ghana. About 2000
newborns are admitted annually. Ethical approval was
given by the Ethical and Protocol Review Committee of
the University of Ghana Medical School.
All newborns hospitalized at the newborn unit in the
first week of life during the study period were eligible
for inclusion. Newborns with clinical indications that
required blood sampling e.g. signs of illness or risk fac-
tors for infection were enrolled. Stable newborns e.g.
infants of diabetic mothers or well preterm infants of
hypertensive mothers who were referred for observationand did not require laboratory investigations, were
excluded. All clinical procedures and laboratory investi-
gations for hospitalized newborns were done according
to standard and departmental guidelines.
A structured questionnaire was used to collect clinical
data on newborn and maternal health during pregnancy,
including use of insecticide treated nets and intermittent
preventive treatment. Other clinical data was extracted
from the ward register and hospital files. Sample size
calculation was based on an estimated prevalence of a
20% risk of congenital malaria in high-risk newborns in
the first week of life [2,11].
Laboratory investigations
Newborn venous blood (1 ml) was collected into EDTA
tubes for haematological investigations. Total white blood
cell count (WBC) with differential, platelet count and red
cell distribution width was measured by an automated
haematology analyzer (Sysmex KX-21) according to man-
ufacturer’s instructions. Thick and thin blood smears pre-
pared from the EDTA sample were stained with Giemsa.
Thin smears were used for malaria parasite species identi-
fication, and the number of asexual parasites per 200
white blood cells (WBC) on the thick smear was multi-
plied by the measured WBC count to obtain the parasite
count per microlitre. An experienced technologist con-
ducted periodic controls of blood slides for quality control.
This traditional method of microscopy was used in 2008
and 2010. In 2010, a rapid diagnosis test (RDT) for identi-
fication of malaria parasite histidine rich protein 2 and lac-
tate dehydrogenase (the First ResponseW malaria antigen
pLDH/HRP2 Combo Test), and a nested PCR methods
were used to identify sub-microscopic parasitaemia.
RDT
The First ResponseW malaria antigen pLDH/HRP2
Combo Test (Premier Medical Corporation Ltd, India) is
designed for the differential diagnosis between Plasmo-
dium falciparum and other plasmodial species. It con-
tains a membrane strip pre-coated with two monoclonal
antibodies as two separate lines across a test strip. One
monoclonal antibody is pan-specific to lactate dehydro-
genase of the Plasmodium species and the other mono-
clonal antibody is specific to histidine-rich protein 2 of
P. falciparum [19].
PCR
This was done at the Noguchi Memorial Institute for
Medical Research, University of Ghana. Parasite DNA
was extracted from whole blood samples spotted on fil-
ter paper, using the TE method [20]. A nested PCR
method for amplification of the merozoite protein 2
(MSP) gene was used for the detection of P. falciparum.
The primary amplification reaction involved the use of
Table 1 Characteristics of newborns tested for congenital
malaria in 2008 and 2010
Newborns in 2008 Newborns in 2010
n = 405 (%) n = 522 (%)
Birth weight
< 2500 grams (LBW) 223 (55) 267 (51)
≥ 2500 grams 182 (45) 255 (49)
Reason for admission
Prematurity/LBW 161 (39.8) 185 (35.4)
Suspected infection 119 (29.4) 152 (29.1)
Perinatal asphyxia 78 (19.3) 110 (21.1)
Jaundice 31 (7.7) 43 (8.2)
Other (birth injury, congenital
anomalies, intrapartum
maternal death)
15 (3.7) 32 (6.1)
Laboratory data
Mean haemoglobin (g/dl) 15.5 (range 4.1 –
23.7)
15.4 (range 5.7 –
23)
Mean white blood cell count
(x 109)
10.4 (range 2.1 –
37.4)
12.8 (range 3 –
23)
There was no difference between subjects’ characteristics in 2008 as compared
to 2010 (p > 0.05 for all parameters).
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TCC ACA G 3’) for a 450-800 base pair product. The
PCR product obtained was used as the template for the
secondary PCR using the following primer pairs: S1 (5’-
GAG TAT AAG GAG AAG TAT G-3’) and S4 (5’-CTA
GAA CCA TGC ATA TGT CC-3’) for a 400-700 base
pair product. The PCR reactions were carried out in a
final volume of 25 μl, which contained 1xPCR buffer
(50 mM KCl, 20 mM Tris-HCl, pH 8.3, 0.1 mg/ml of
gelatin), 3.5 mM MgCl2, 200 μM dNTP mix, 1 μM of
each primer, 1U Taq polymerase and 5 μl of DNA tem-
plate for primary amplification. The secondary reaction
contained 1xPCR buffer (50 mM KCl, 20 mM Tris-HCl,
pH 8.3, 0.1 mg/ml of gelatin), 2.5 mM MgCl2, 200 μM
dNTP mix, 1 μM of each primer, 1U Taq polymerase and
1μl of DNA amplicon. PCR was carried out using a
DNA Engine Tetrad PTC-225 thermal cycler (MJ Re-
search, USA) with cycling parameters of an initial melt
at 94°C for 3mins followed by 30 cycles of 94°C for
25secs, 42°C for 1 min, 65°C for 2 minutes and a final
cycle of 72°C for 3mins. The cycling parameters for the
secondary reaction was 94°C for 3mins followed by
30 cycles of 94°C for 25secs, 50°C for 1 min, 70°C for
2mins and a final cycle of 72°C for 3mins. PCR products
were run on a 2% ethidium bromide stained agarose gel.
The PCR assay detects one parasite per microlitre of
blood and has about 97% sensitivity and 100% specificity
to detect P. falciparum.
Data analysis
Laboratory data was entered into a designated register. All
data were subsequently entered into a database (Access
2007 for Windows, Microsoft Corporation, USA). Data ana-
lysis was by descriptive and inferential statistics. Pearson's
chi square test (or Fisher's exact test as appropriate) was
used to compare proportions.
Results
In 2008, 405 newborns aged 0 – 7 days were tested in
the first week of life. In 2010, 522 newborns admitted
to the unit in the first week of life were tested during
the course of their hospitalization (aged 0 – 28 days),
of these 443 (84.9%), were tested in the first week of
life. The number and selected demographic and clin-
ical characteristics of newborns admitted during both
study periods are shown in Table 1. There was no dif-
ference in the morbidity pattern of newborns during
both periods.
Nine (2.2%) of the 405 newborns tested in 2008 had
P. falciparum parasitaemia by microscopy, all of which
were of low parasite density (≤50 per μl). Four (44%) of
the nine newborns were LBW and also born prema-
turely. Of the nine affected newborns, two were asymp-
tomatic preterm LBW newborns who needed specialcare, three had suspected sepsis (they had no fever) be-
cause of risk factors for neonatal infection in their
mothers’ obstetric history, three had perinatal asphyxia
and one newborn was admitted on the 7th day of life
with low grade fever and moderate jaundice. The mean
haemoglobin and WBC in newborns with congenital
malaria was [15.5 g/dl (range 13.2 – 17.8)] and [10.5 ×
109 (range 4.2 – 19.4)] respectively. There was no stat-
istical difference in the haematological indices of con-
genital malaria cases as compared with non-affected
newborns (see Table 1). Affected newborns were treated
with amodiaquine 10 mg/kg/day according to depart-
mental guidelines.
None of the 522 newborns recruited in 2010 had para-
sitaemia by microscopy or RDT. All 522 samples were
tested by PCR, results were obtained in 467/522 and 56
(12%) newborns were positive for P. falciparum. The
prevalence of LBW in the PCR parasitaemia-positive
newborns was 55% as compared to 41.9% in those who
were PCR parasitaemia-negative [p = 0.1; RR 1.3 (95% CI
0.9 – 1.74)]. The mean haemoglobin (14.6 g/dl vs.
15.3 g/dl) and WBC (14.6 × 109 vs. 16.4 × 109) in those
with parasitaemia vs. those without parasitaemia respect-
ively was not statistically different.
Data collected from mothers about their health and
malaria preventive practices (use of insecticide treated
nets and intermittent preventive treatment) during preg-
nancy were not analyzed because the information could
not be verified.
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This study shows that patent malaria parasitaemia was
uncommon in untreated high-risk newborns referred to
Korle Bu Teaching hospital in southern Ghana during
the peak seasons for malaria in 2008, and 2010. The
2.2% congenital malaria prevalence by microscopy in the
2008 cohort was lower than rates from longitudinal
studies from neighbouring countries, 5.1% in Nigeria
and 4.7% in Ivory Coast [8,9]. The data also suggests
that congenital malaria is mostly asymptomatic with no
pathognomic clinical features and that affected new-
borns have low parasitaemia; these findings are similar
to work reported by others [21,22].
Several hospital-based studies from the West African
sub-region have reported high prevalence of malaria in
newborns [23,24]. The reasons for the variable prevalence
of congenital malaria in these countries of similar endem-
icity as Ghana are unclear. Possible explanations could be
differences in malaria prevention coverage during preg-
nancy or laboratory operational factors. Traditional micros-
copy in routine service laboratories may over-diagnose
malaria, and has been shown to have a poor positive pre-
dictive value when compared with microscopy from
research laboratories [25,26].
The PCR method diagnoses congenital malaria more
frequently because of its ability to detect parasite macro-
molecules and not necessarily live parasites [21]. The
clinical importance and significance of malaria parasit-
aemia diagnosed by PCR alone is uncertain [27]. Even
though it is suggestive of placental parasitaemia and the
consequent effects of LBW and prematurity but its rele-
vance as a significant cause of clinical illness in the first
week of life is doubtful. However, recent evidence sug-
gests that P. falciparum malaria parasites in the placenta
as detected by PCR are more likely to result in congeni-
tal malaria in the infant during the first three months of
life [28].
Most widely used RDTs are based on the detection of the
histidine-rich protein 2 (HRP2) product of the P. falciparum
hrp2 gene. The sensitivity and specificity of this method
has been shown to range from 90-95% and 85-92% re-
spectively. However, relative to thick smear microscopy,
recent studies have shown that false negative RDT results
occur in persons with asymptomatic P. falciparum infec-
tions as in our patients. The false negatives are thought to
result from spontaneous deletion of the histidine-rich re-
peat region of the hrp2 gene [29].
The data from this study and previous community-
based study on congenital malaria in Ghana [15] shows
that congenital malaria is an uncommon cause of neo-
natal morbidity in Ghana. A large-scale hospital-based
surveillance study in Kenya from 2002 - 2009 found a
declining trend in the prevalence of congenital malaria;
newborns (0.5%) who had malaria parasitaemia presentedbefore 2005 [30]. Other workers have also shown a declin-
ing trend in malaria disease in recent years [31,32]. These
studies suggest that clinical congenital malaria is not a sig-
nificant cause of the high neonatal morbidity and mortal-
ity in sub-Saharan Africa. It is therefore important that
sub-Saharan African countries with endemic malaria
should urgently review newborn care guidelines for pri-
mary health care workers so as to reduce delays in the re-
ferral and appropriate management of sick newborns.
This study has some limitations. Though one of the
objectives was to identify the impact of maternal malar-
ial preventive practices in pregnancy on the prevalence
of congenital malaria, we could not collect accurate data
on maternal practices. It was difficult to verify that those
who said they had used insecticide treated nets during
pregnancy actually did so. Also, the information mothers
gave on intermittent anti-malarial prophylaxis was not
always recorded in the available maternal health records.
Conclusion
The data from this study does not support empirical treat-
ment for malaria in sick newborns in Ghana. Laboratory
confirmation of malaria in newborns should be done and
other causes of clinical illness excluded before anti-
malarial drugs are prescribed for newborns especially in
the first week of life. The prevalence of malaria as detected
by PCR in this study could be used to make a case for im-
proving malaria preventive practices during pregnancy
thus reducing placental malaria - a known cause of LBW
and a pre-requisite for congenital malaria. Early referral of
sick newborns to health facilities with adequate skills for
early diagnosis and appropriate management is recom-
mended. Concerted effort to reduce empirical prescription
of anti-malarial drugs for newborns is needed. Data such
as presented in this study could be used in continuing
educational programs to improve knowledge and influ-
ence the practice of frontline health care providers.
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